Two metabolites of sulphinpyrazone and their identification and determination by mass spectrometry
- 1 September 1981
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 33 (1) , 89-92
- https://doi.org/10.1111/j.2042-7158.1981.tb13717.x
Abstract
Sulphinpyrazone is an antiplatelet agent in vivo and in vitro. Two active metabolites, a sulphide (S) and a hydroxylated sulphide (S-OH) have been identified in rabbit and human plasma and a selective and sensitive g.c.-m.s.-method for quantitative determination of the sulphide and hydroxylated sulphide in plasma and urine has been evolved which allows concentrations down to 5 ng ml−1 for the sulphide and 30 ng ml−1 for the hydroxylated sulphide to be detected. The time course of the metabolite concentrations in plasma corresponds to the biological findings, suggesting that the metabolites contribute significantly to the in vivo effects of the drug.This publication has 9 references indexed in Scilit:
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- Two new metabolites of sulfinpyrazone in the rabbit: A possible cause of the prolonged effectThrombosis Research, 1979
- Determination of sulfinpyrazone and two of its metabolites in human plasma and urine by gas chromatography and selective detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1979
- The prolonged effect of sulfinpyrazone on collagen-induced platelet aggregation in vivoThrombosis Research, 1978
- C‐Glucuronides, a Novel Type of Drug MetabolitesHelvetica Chimica Acta, 1975
- Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease.Circulation, 1975
- Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan®) in manEuropean Journal of Clinical Pharmacology, 1975
- Altered Platelet Function in Patients with Prosthetic Mitral Valves Effects of Sulfinpyrazone TherapyCirculation, 1970
- A POTENT NEW URICOSURIC AGENT, THE SULFOXIDE METABOLITE OF THE PHENYLBUTAZONE ANALOGUE, G-256711957